Randomized, Open-label Phase II Trial to Assess the Safety and Immunogenicity of MVA-BN Smallpox Vaccine in Immunocompromised Subjects With HIV Infection
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Edgar T Overton, MD
University of Alabama at Birmingham
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Clinical Research Puerto Rico, Inc.
San Juan, PR, Puerto Rico
- Fundacion de Investigacion
San Juan, PR, Puerto Rico
- University of Alabama at Birmingham
Birmingham, Alabama, United States
- Health for Life Clinic Little Rock
Little Rock, Arkansas, United States
- Quest Clinical Research
San Francisco, California, United States
- Dupont Circle Physicians Group
Washington D.C., District of Columbia, United States
- Infectious Disease Associats of Nw Florida Center for Prevention and Treatment of Infections Infectious Diseases Associates of Nw Fl
Pensacola, Florida, United States
- Rowan Tree Medical
Wilton Manors, Florida, United States
- University of Illinois - Chicago
Chicago, Illinois, United States
- University of Iowa Departments of Internal Medicine and Microbiology University of Iowa
Iowa City, Iowa, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- University of Pennsylvania Clinical Trials Unit
Philadelphia, Pennsylvania, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Apr 2014
- Primary completion
- 10 May 2017
- Completion
- 10 May 2017
- Last update posted
- 2 Apr 2020
- Registered enrollment
- 87
- Registry id
- NCT02038881
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.